Clinical Trial Update: Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II trial updating the combination of vemurafenib and sorafenib in pancreatic cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Zelboraf (vemurafenib)

Snippet

Sponsor: HonorHealth Research Institute | Conditions: Pancreas Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-03-30